Acadian Asset Management LLC Celcuity Inc. Transaction History

Acadian Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$17.35 - $24.87 $50,662 - $72,620	-2,920 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$14.25 - $30.93 $41,610 - $90,315	2,920 New	2,920 $70,000
Q2 2019 Aug 08, 2019	SELL	$19.88 - $25.0 $38,388 - $48,275	-1,931 Closed	0 $0
Q1 2019 May 09, 2019	SELL	$18.38 - $24.44 $52,677 - $70,045	-2,866 Reduced 59.75%	1,931 $42,000
Q3 2018 Oct 30, 2018	BUY	$20.96 - $30.77 $37,015 - $54,339	1,766 Added 58.26%	4,797 $138,000
Q2 2018 Jul 24, 2018	BUY	$16.13 - $26.99 $48,890 - $81,806	3,031 New	3,031 $75,000

107

30.3M

30.8K

152K

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $195M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.